MarketBeat Compares Ginkgo Bioworks and MindWalk Holdings Corp. Ratings
What happened
MarketBeat published a comparison of Ginkgo Bioworks and MindWalk Holdings Corp., analyzing metrics such as institutional ownership, revenue, and earnings per share. The report noted that MindWalk Holdings Corp. has higher earnings but lower revenue than Ginkgo Bioworks. MindWalk Holdings Corp. also trades at a lower price-to-earnings ratio than Ginkgo Bioworks.
From themarketsdaily.com
Why it matters
The comparison highlights differing market perceptions between the two small-cap healthcare companies. For example, Ginkgo Bioworks has significantly higher institutional ownership at 78.6% compared to 6.7% for MindWalk Holdings Corp. Analyst recommendations provided by MarketBeat show a potential downside for Ginkgo Bioworks, while MindWalk Holdings Corp. has a consensus target price indicating a potential upside.
From themarketsdaily.com
Who's involved
- MarketBeatProvided analyst recommendations and financial comparisons for the companies.
- Ginkgo BioworksWas compared against MindWalk Holdings Corp. based on valuation and ownership metrics.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Ginkgo BioworksSpeculative
Ginkgo Bioworks might see its market price affected by the analyst comparison suggesting downside risk.
Keep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Ginkgo Bioworks
American biotechnology company
Nothing else this week.
Related events
- MarketBeat provided analyst recommendations and financial comparisons for Vertiv and Tigo Energy.
- MarketBeat reported analyst recommendations, noting that both MarketBeat and Jefferies Financial Group are mid-cap finance companies.
- MarketBeat reported analyst recommendations for small-cap finance companies Perella Weinberg Partners and Fidus Investment.